Genmab A/S
GMAB
$25.85
-$0.51-1.94%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 3.48B | 3.23B | 3.34B | 3.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 3.48B | 3.23B | 3.34B | 3.23B |
| Cost of Revenue | -- | 192.27M | 158.39M | 163.27M | 148.27M |
| Gross Profit | -- | 3.29B | 3.07B | 3.17B | 3.08B |
| SG&A Expenses | -- | 593.72M | 560.96M | 578.72M | 577.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 2.28B | 2.15B | 2.23B | 2.19B |
| Operating Income | -- | 1.21B | 1.09B | 1.11B | 1.04B |
| Income Before Tax | -- | 1.47B | 1.32B | 1.36B | 1.36B |
| Income Tax Expenses | -- | 178.77M | 185.02M | 195.77M | 203.77M |
| Earnings from Continuing Operations | -- | 1.30K | 1.13K | 1.16K | 1.16K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 1.30B | 1.13B | 1.16B | 1.16B |
| EBIT | -- | 1.21B | 1.09B | 1.11B | 1.04B |
| EBITDA | -- | 1.25B | 1.13B | 1.15B | 1.07B |
| EPS Basic | -- | 20.53 | 17.80 | 18.24 | 18.14 |
| Normalized Basic EPS | -- | 12.92 | 12.69 | 11.98 | 11.72 |
| EPS Diluted | -- | 20.39 | 17.66 | 18.10 | 17.99 |
| Normalized Diluted EPS | -- | 12.83 | 12.60 | 11.89 | 11.62 |
| Average Basic Shares Outstanding | -- | 252.51M | 255.19M | 255.19M | 256.33M |
| Average Diluted Shares Outstanding | -- | 254.08M | 256.85M | 256.94M | 258.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |